RNS Number : 6843P
06 October 2011
6 October 2011
("Ultrasis" or the "Company")
Launch of US version of Beating the Blues
Ultrasis, the leading provider of cognitive behavioural therapy for stress and mild depression delivered by computer, is pleased to announce the formal launch of U Squared Interactive LLC ("U(2)"), its 50:50-owned joint-venture with UPMC Insurance Services, which will be used to launch the US-specific version of "Beating the Blues" ("BtB US") to the American market.
In addition, Ultrasis is pleased to announce the completion of the development BtB US which will be marketed in the US via U(2), and for which U(2) is currently in ongoing discussions with a number of interested parties.
For further details, please visit: www.U2interactive.com and www.beatingthebluesus.com.
As previously announced on 27 February 2011, both Ultrasis and UPMC will invest to develop and drive sales opportunities across US states, government bodies, insurers, primary care providers, major corporations and other health care providers, who seek to enhance their mental health and well-being services.
For further information contact:
Ultrasis plc Tel: +44 (0) 20 7535 2050
Nigel Brabbins, CEO
Strand Hanson Limited Tel: +44 (0) 20 7409 3494
Stuart Faulkner / Liam Buswell
JBP Public Relations Tel: +44 (0) 11 7907 3414
Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and internationally.
Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy ("CBT") and interactive multimedia and is the world leader in this field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions.
Beating the Blues is an eight-week, web-based treatment programme for mild and moderate depression based on CBT.
Following a rigorous examination by the National Institute for Health and Clinical Excellence ("NICE"), Beating the Blues was approved by NICE in February 2006 for use in the National Health Service.
For more information on Ultrasis please visit www.ultrasis.com.
This information is provided by RNS
The company news service from the London Stock Exchange